ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 253272 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 253272; 2) Community: the network communities that were significantly associated with the response to NSC 253272; 3) Molecule: the relationships between components within communities and NSC 253272; 4) MDR: the compounds that were significantly associated with the NSC 253272.

NSC Compound Enrichment Correlation
NSC 658387 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- 0.00640068043275767 0.70619656
NSC 668844 Null 0.00640068043275767 0.80607977
NSC 670558 Null 0.00640068043275767 0.56106613
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.00640068043275767 0.47216401
NSC 692587 ethyl-8-(4-chlorophenyl)-4-methyl-2-oxo-6-(thiophen-2-yl)-4a,7-dihydro-2H-chromene-3- carboxylate 0.00640068043275767 0.58519122
NSC 731527 cyanoaminopyranopyridine derivatives 0.00640068043275767 -0.28492772
NSC 17065 Null 0.00640068043275772 0.1435125
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.0070129549950601 0.7383767
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.00701295499506013 0.76879162
NSC 660334 Null 0.00701295499506013 0.79631132
Total:103  Current:25    [First] [Prev] [Next] [Last]